ArticleFrontiers in veterinary science2025
Prevalence of Bluetongue and the distribution of
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bluetongue virus (BTV) is a significant vector-borne pathogen affecting ruminants, leading to substantial economic losses, and adversely impacting livestock production worldwide. Recently, Bluetongue (BT) has emerged as a growing concern for European and Asian countries, including Kazakhstan. This study examines the prevalence and distribution of BTV in Kazakhstan during 2023-2024, providing up-to-date information on its occurrence in livestock and Methods: A total of 972 whole blood and 972 serum samples were collected from cattle, sheep, and goats in the southern and northern regions of Kazakhstan, alongside 11,859 Result: The overall seroprevalence of BTV in Southern Kazakhstan increased across all animal species in 2024 compared to 2023, with goats showing the most notable rise (from 3.8% to 29.5%). In the northern regions, seroprevalence remained zero in 2023 but reached 10.0% in cattle by 2024. rRT-PCR results confirmed active virus circulation, with rRT-PCR-positive samples significantly higher in 2024, especially among goats (from 4.2% in 2023 to 62.0% in 2024) and cattle (from 9.2% to 34.4%). Based on morphology, nine species of Discussion: This study provides new insights into the epidemiology of BT in Kazakhstan and serves as a valuable resource for veterinary professionals. The findings emphasize the need for continued surveillance and vector control strategies to mitigate the spread of BTV in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.